WebMar 9, 2024 · Evofem recently launched the first new non-hormonal birth control option in decades. Clinical efficacy falls short of the copper IUD, PARAGARD, but that device I believe may come with significant ... WebHistorical Stock Price. Select the date below to view the historical closing price for that particular day. The closing price is not indicative of future price performance. Historical Stock Prices are provided for informational purposes only and are not intended for …
Did you know?
WebView the latest Evofem Biosciences Inc. (EVFM) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebApr 10, 2024 · EVOFEM BIOSCIENCES, INC. ... Name of exchange on which registered Common stock, par value EVFM OTCQB $0.0001 per share Indicate by check mark whether the registrant is an emerging growth company ...
WebApr 6, 2024 · 62,6%. More Financials. Company. Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from … WebApr 10, 2024 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Evofem Biosciences stock is Hold based on the current 1 sell rating, 1 hold rating and 2 buy ratings for EVFM. The average twelve-month price prediction for Evofem …
WebMay 5, 2024 · May 05, 2024, 09:00 ET. SAN DIEGO, May 5, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) (the "Company") today announced that the Board and stockholders of the Company approved a 1 ... WebApr 6, 2024 · Over the last 12 months, Evofem Biosciences's shares have ranged in value from as little as $0.013 up to $3.8685. A popular way to gauge a stock's volatility is its "beta". Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evofem Biosciences's is -1.2055.
WebApr 12, 2024 · Evofem Biosciences Inc’s trailing 12-month revenue is $20.2 million with a -589.0% profit margin. Year-over-year quarterly sales growth most recently was 276.5%. Analysts expect adjusted earnings to reach $-7.960 per share for the current fiscal year. Evofem Biosciences Inc does not currently pay a dividend. The outlook for the ...
WebApr 14, 2024 · SAN DIEGO, April 14, 2024--Evofem Biosciences, Inc., (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced the appointment of Ivy Zhang as Chief Financial Officer (CFO) and Secretary, effective April 13, 2024.Reporting to Chief Executive Officer Saundra Pelletier, Ms. Zhang will lead … different obstacles to overcomeWebMay 18, 2024 · Each share of common stock is being sold together with one short-term warrant to purchase one share of common stock at a combined public offering price of $1.00 per share of common stock and ... formeleingabe wordWebMar 17, 2024 · SAN DIEGO, March 21, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced it has implemented measures to lower its operating expenses, with the goal of reaching cash flow break even by year-end 2024. These measures include a 39% reduction of payroll expenses through a combination of: … formeleditor word tastenkürzelWebThe Evofem Biosciences 52-week high stock price is 8.04, which is 1575% above the current share price. The Evofem Biosciences 52-week low stock price is 0.28, which is 41.7% below the current share price. The average Evofem Biosciences stock price for … formel eins newsWebEvofem Biosciences Discusses Innovative Woman-Controlled Contraceptive with The Stock Day Podcast. Phoenix, Arizona--(Newsfile Corp. - August 1, 2024) - The Stock Day Podcast welcomed Evofem Biosciences (NASDAQ: EVFM) ("the Company"), an … different occupations in psychologyWebMar 5, 2024 · On the bottom line, Evofem Biosciences reported a net loss of $40.6 million, or $0.50 per share, compared to a net loss of $12.7 million ($0.27 per share) it recorded during the prior-year quarter ... different occupations in the art fieldWebApr 6, 2024 · EVOFEM BIOSCIENCES, INC. analysts consensus, targets, ratings and recommendations OTC Markets: EVFM OTC Markets ... New Historical Highs. New Historical Lows. Long Term. Top Fundamentals. Top Fundamentals. Sales growth. … formeleins facebook